Authorities in China have approved a drug for the treatment of Alzheimer's disease, the first new medicine with the potential to treat the cognitive disorder in 17 years.
中国有关部门已批准一种治疗阿尔茨海默症的药物,这是17年来首个可能对这种认知障碍有治疗效果的新药。
The seaweed-based drug, called Oligomannate, can be used for the treatment of mild to moderate Alzheimer's, according to a statement from China's drug safety agency.
中国药品安全监督管理局发表的一份声明显示,这个被称为甘露特钠胶囊的海藻类药物可以用于治疗轻度至中度的阿尔茨海默症。
The approval is conditional however, meaning that while it can go on sale during additional clinical trials, it will be strictly monitored and could be withdrawn should any safety issues arise.
然而,批准是有条件的,虽然它可以在额外的临床试验期间上市销售,但将受到严格监督,如果出现任何安全问题,可能会被撤回。
In September, the team behind the new drug, led by Geng Meiyu at the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences, said they were inspired to look into seaweed due to the relatively low incidence of Alzheimer's among people who consume it regularly.
这一新药的研究团队由中国科学院上海药物研究所的耿美玉带领,他们在九月份说受到启发研究海藻是因为经常食用海藻的人中阿尔茨海默症的发病率相对较低。
In a paper in the journal Cell Research, Geng's team described how a sugar contained within seaweed suppresses certain bacteria contained in the gut which can cause neural degeneration and inflammation of the brain, leading to Alzheimer's.
耿美玉的团队在《Cell Research》杂志的一篇论文中描述了海藻中的糖如何抑制肠道中某些细菌的,这些细菌会导致神经退化和大脑炎症,从而导致老年痴呆。
This mechanism was confirmed during a clinical trial carried out by Green Valley, a Shanghai-based pharmaceutical company that will be bringing the new drug to market.
这一机制在上海的绿谷制药公司进行的临床试验中得到了证实,该公司将把这种新药推向市场。
Conducted on 818 patients, the trial found that Oligomannate -- which is derived from brown algae -- can statistically improve cognitive function among people with Alzheimer's in as little as four weeks, according to a statement from Green Valley.
绿谷制药公司发布的声明中说,对818位病人进行的临床试验发现从统计数据来看,用褐藻提取物制成的甘露特钠胶囊在短短四周内就能改善老年痴呆人群的认知功能。
"These results advance our understanding of the mechanisms that play a role in Alzheimer's disease and imply that the gut microbiome is a valid target for the development of therapies," neurologist Philip Scheltens, who advises Green Valley and heads the Alzheimer Center Amsterdam, said in the statement.
神经学家Philip Scheltens是绿谷制药公司顾问,也是阿姆斯特丹阿尔茨海默症中心负责人,他在声明中说:“这些结果促进了我们对阿尔茨海默症发病机制的理解,并暗示肠道微生物群是治疗发展的有效靶点。”
雅思听力租房场景常考题目类型及技巧
雅思听力备考相关问题解答
雅思听力6分的学习计划表分享
雅思听力简化符号笔记分享:字母、图像
雅思听力考试中的易混同音词汇整理
雅思听力考试的三种备考方案
详解雅思听力考试中的六个陷阱
雅思听力必须了解的缩略词
注意4个要点 雅思听力失误可以避免
解读雅思听力的四种替换规律
避免雅思听力考试出现失误的准备方法
专家解析雅思听力的七大陷阱
雅思听力材料的选择和练习方法介绍
半个月提高雅思听力1.5分的练习方法
雅思听力备考过程中需要注意哪些方面
雅思听力场景重要词汇大全
给新手的14个雅思听力tips
雅思听力最常见的60个核心词汇
详解雅思听力考试中的同义转换
从四个方面有效地提高雅思听力成绩
雅思听力高分需要关注的四个部分
雅思听力考试和答题过程的注意事项
浅谈真正提高雅思听力水平的几个要点
雅思听力健康场景高频词汇点拨
文化常识对雅思听力的提升作用
掌握雅思听力高分的三大策略
雅思听力七大陷阱见招拆招
雅思听力完成句子题的五大答题要领
解析雅思听力中的缩写词:字母、图像
细数雅思听力的24条高分技巧
不限 |
英语教案 |
英语课件 |
英语试题 |
不限 |
不限 |
上册 |
下册 |
不限 |